Delta-like ligand 3: A promising target against small cell lung cancer.
Xin NieYu-Meng TianYue YuanLin LiPublished in: Aging medicine (Milton (N.S.W)) (2024)
This commentary highlighted the current knowledge about novel DLL3-targeting agents for refractory small cell lung cancer.